Alain Chetrit is our third impact voice of the 15 impact voices in 15 days series.
Alain founded LabConnect; a company specializing in global central laboratory services, designed to support clinical trials across various therapeutic areas. The company has been involved in over 1,600 clinical research trials across multiple therapeutic areas, including cell and gene therapy (ATMP), vaccines, and oncology.
He is also the co-founder of the Knowledge Impact Network, an organization that focuses on leveraging the knowledge and experience of global leaders to support social entrepreneurs in scaling their impact. KIN's mission is to facilitate knowledge sharing for social good, aiming to address critical global issues through collaborative efforts.
#15ImpactVoicesin15Days - Impact Voice 3 馃殌
Alain Chetrit is the Executive Chairman of Knowledge Impact Network and Co-Founder of LabConnect, which has 750 employees globally. He's a passionate advocate for impact investing.
Checkout his impact investing story 猬囷笍